lecture 6 Flashcards

1
Q

Occupancy Model

A

The drug effect depends on the number of receptor site occupied by the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rate Model

A

The drug effect depends on the number of encounters the drug make with the receptor per unit time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Induction Model

A

The drug effect is caused by conformational changes which the drug causes in the active binding site of the receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Perturbation Model

A

The drug effect is caused by macromolecules disturbances or perturbations. The disturbances caused by agonists different from antagonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Co-operativity Model

A

In this case the receptor is in between activated and inactivated states. Agonists can shift it towards activated state and antagonists can shift it towards inactivated state.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Receptor Pharmacology

A

The current pharmacological concept of four receptor super-families provides a useful framework for interpreting most drug-receptor interactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Type 1 ionotropic receptor: Ligand-gated ion channel

A
  • nAChR has 5 subunits surrounding an ion pore
  • It has a fast response
  • It’s membrane bound
  • Direct connection of the units to the ion channel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type 2 metabotropic receptor: G-protein coupled receptor

A
  • Membrane proteins that help to convert extracellular signals into intracellular response
  • Fast response (secs)
  • Membrane bound
  • Has 7 transmembrane helices
  • Indirect coupling with the G- protein and the effector inside the cell.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type 2 metabotropic receptor: G-protein coupled receptor

A
  • Membrane proteins that help to convert extracellular signals into intracellular response
  • Fast response (secs)
  • Membrane bound
  • Has 7 transmembrane helices
  • Indirect coupling with the G- protein and the effector inside the cell.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type 3 receptor: Kinase-linked receptor

A
  • Don’t use membrane proteins, an extracellular binding to these receptors causes an intracellular kinase activity.
  • Slow response (hours)
  • membrane bound
  • Direct coupling to enzyme
  • Single- Trans- Membrane helix
  • Direct linkage between receptor and kinase enzyme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type 4 receptor: Nuclear receptor

A
  • located inside the cell, for steroid hormones other related molecules.
  • They are found in cytoplasm/ nucleus
  • Slow response (hour)
  • Intracellular
  • Effect on gene transcription
  • Coupling via DNA
  • Has a structure is a receptor and DNA binding domain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Types of targets (RICE) for Molecular Interactions

A
  • Receptor
  • Ion Channels
  • Carriers
  • Enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the agonist for Nicotinic Acetylcholine receptor (Receptor)

A

Nicotine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Properties of Nicotine

A
  • Alkaloid from tobacco plants
  • Agonist of nicotinic acetylcholine receptor
  • Stimulanting drug [Parasympathomimetic]
  • Potential toxic side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the agonist for Beta-adrenoreceptor (Receptor)

A

Isoprenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

properties of Isoprenaline

A
  • beta-adrenergic agonist
  • structural similarity to adrenaline
  • treatment of slow heart rate [bradycardia]
17
Q

What is the modulator for Voltage-dep. Na+-channel (Ion- Channel)

A

Lidocaine

18
Q

properties of Lidocaine

A
  • Local anesthetic
  • Common usage as:
  • Injected form for dental anesthesia
  • Injected form for minor surgery
  • Topical form to relieve pain from skin inflammations
19
Q

What is the modulator for Voltage-dep. Ca2+-channel (Ion- channel)

A

Nifedipine

20
Q

Properties of Nifedipine

A
  • Dihydropyridine
  • L-type calcium channel
    blocker
  • Usage as:
  • anti-anginal drug
  • antihypertensive agent
21
Q

What is an inhibitor of Acetylcholinesterase (Enzyme)

A

Neostigmine

22
Q

Properties of Neostigmine

A
  • Reversible inhibitor of acetylcholinesterase
  • Interference with the breakdown of physiological ligand acetylcholine - Indirect stimulation of nicotinic and muscarinic receptors
  • Usage in:
  • Reversal of the effects of non-depolarizing muscle relaxants following anesthesia
  • Treatment of myasthenia gravis to increase NMJ stimulation
23
Q

What is an inhibitor of Cyclooxygenase (Enzyme)

A

Aspirin

24
Q

Properties of Aspirin

A
  • Non-steroidal anti-inflammatory drug [NSAID]
  • Inhibitor of the enzyme cyclooxygenase [COX-1>COX-2] - Usage as:
  • Analgesic
  • Anti-platelet drug
25
Q

What is an inhibitor of Choline carrier (Carrier)

A

Hemicholinium

26
Q

Properties of Hemicholinium

A
  • Blocks choline uptake
  • Not used clinically
  • Neuromuscular blocking drug
27
Q

What is an inhibitor of Na+/K+-pump (Carrier)

A

Ouabain

28
Q

Properties of Ouabain

A
  • Cardiac glycoside
  • Blocker of Na+/K+-ATPase
  • Increases [Ca2+]i due to decreased NCX
  • Therapeutic usage in heart failure
  • Potential toxicity
29
Q

Plasmalemma excitation

A

Key ion channels and ion pumps involved in maintenance of membrane potential and triggering of action potential